SDH of HPV Vaccine Completion
NCT03709602 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3076
Last updated 2020-09-01
Summary
The purpose of this research study is to find out which factors influence parents' ability to complete the human papillomavirus (HPV) vaccine series for their child. The information learned from this study may help the investigators develop programs to improve HPV vaccine completion rates among adolescents and reduce barriers to receiving the second shot of the vaccine series.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Rosa Gonzalez-Guarda, PhD · Duke University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-07
- Primary Completion
- 2019-12-17
- Completion
- 2019-12-17
Countries
- United States
Study Locations
More Related Trials
-
Improving HPV Vaccination Rates Among Rural and Native American Adolescents
NCT03801603 ·Status: COMPLETED ·Phase: NA
-
Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies
NCT05831540 ·Status: TERMINATED ·Phase: NA
-
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination
NCT03442062 ·Status: COMPLETED ·Phase: NA
-
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
NCT06243666 ·Status: ACTIVE_NOT_RECRUITING
-
Alternate Dosing Schedules Study for HPV Vaccine (ADS)
NCT02280642 ·Status: COMPLETED
-
Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students
NCT06631794 ·Status: NOT_YET_RECRUITING
-
Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)
NCT00365378 ·Status: COMPLETED ·Phase: PHASE2
-
HPV Ends Here: Increasing Uptake of the HPV Vaccine
NCT06831929 ·Status: RECRUITING ·Phase: NA
-
Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting
NCT00572832 ·Status: COMPLETED ·Phase: NA
-
Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability
NCT04945655 ·Status: COMPLETED ·Phase: NA
-
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
NCT01984697 ·Status: COMPLETED ·Phase: PHASE3
-
Video to Promote HPV Vaccination
NCT02196454 ·Status: COMPLETED ·Phase: NA
-
Alternate Dosing Schedules Study for HPV Vaccine
NCT00862810 ·Status: COMPLETED ·Phase: PHASE4
-
Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
NCT00546078 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)
NCT00517309 ·Status: COMPLETED ·Phase: PHASE3
-
PREVENT Pilot HPV - Related Cancers Trial
NCT06738355 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
NCT01030562 ·Status: COMPLETED
-
An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination
NCT03628885 ·Status: COMPLETED ·Phase: NA
-
Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study
NCT02100618 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects
NCT03929172 ·Status: COMPLETED ·Phase: PHASE1
-
HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents
NCT04438291 ·Status: COMPLETED ·Phase: NA
-
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
NCT04722822 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Long-term HPV Vaccine Efficacy
NCT01393470 ·Status: UNKNOWN
-
Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting
NCT01184079 ·Status: COMPLETED ·Phase: NA
-
Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults
NCT00120848 ·Status: COMPLETED ·Phase: PHASE2